What is a Generic Drug?
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Airsupra (Albuterol/Budesonide)
Prescription Required
We don't have this generic product yet!
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
-
Product Details
Description
Airsupra (albuterol and budesonide) is an inhaler used to treat or prevent bronchoconstriction and to decrease the risk of worsening asthma in patients who are at least 18 years old.
Airsupra is available as a pressurized metered dose inhaler. Each actuation delivers 90 mcg of albuterol and 80 mcg of budesonide.
Fact Table
Formula
C13H21NO3 (Albuterol), C25H34O6 (Budesonide)
License
US FDA
Bioavailability
10-20% (Albuterol, inhaled), 38% (Budesonide, inhaled)
Legal status
Prescription only (Rx)
Chemical Name
Albuterol, Budesonide
Elimination half-life
3.8-6 hours (Albuterol), 2-3.6 hours (Budesonide)
Dosage (Strength)
90 mcg Albuterol/80 mcg Budesonide per inhalation
Pregnancy
Consult a doctor
Brands
Airsupra
Protein binding
10% (Albuterol), 88% (Budesonide)
PubChem CID
2083 (Albuterol), 5281004 (Budesonide)
MedlinePlus
a682145 (Albuterol), a608007 (Budesonide)
ChEBI
CHEBI:2549 (Albuterol), CHEBI:3207 (Budesonide)
ATC code
R03AK10
DrugBank
DB01001 (Albuterol), DB01222 (Budesonide)
KEGG
D07551 (Albuterol), D00244 (Budesonide)
Routes of administration
Inhaled
Directions
Use Airsupra as prescribed by your doctor. Your doctor will determine an appropriate treatment regimen for you.
Carefully read the medication guide that comes with your prescription for information on how to properly use the inhaler. Talk to your doctor or pharmacist about any questions or concerns you may have.
Recommended dosing: Inhale two puffs by mouth as needed. Do not exceed more than 6 doses (12 inhalations) within 24 hours. The inhaler should be primed before using it for the first time. It should be re-primed if it has not been used for more than 7 days, if it is dropped, or after cleaning.
Store Airsupra in a dry place away from heat and light exposure. Keep away from children. Keep at room temperature between 20°C to 25°C (68°F to 77°F). Properly discard when the counter reads “0”.
Tell your doctor or pharmacist if you have any questions or concerns about the inhaler.
Ingredients
The active ingredients in Airsupra are albuterol and budesonide.
Inactive ingredients include hydrofluoroalkane (HFA 134a) and porous particles 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC) and calcium chloride.
Contraindications
Patients with an allergy to albuterol, budesonide, or to any of the excipients should not use Airsurpa.
Cautions
- Before you start using Airsupra, talk to your doctor about:
- All the prescription and over-the-counter medications you take
- Your allergies
- Your current health problems and past medical history
- Your pregnancy or breastfeeding status
- Airsurpa is associated with the following warnings and precautions:
- Paradoxical bronchospasm
- Cardiovascular effects
- Hypersensitivity reactions
- Low potassium levels in the blood
- Worsening of infections, including tuberculosis, fungal, bacterial, viral, or parasitic infections or herpes simplex of the eyes
- Fungal infections of the mouth or throat. Patients should be advised to rinse their mouth with water and spit after inhalation.
- Hypercorticism and adrenal suppression, especially at high doses in patients who are susceptible
- Glaucoma and cataracts
- Do not use more than the maximum recommended dosage, as death can occur with excessive use.
- Patients with convulsive disorders, hyperthyroidism, diabetes, and ketoacidosis should exercise caution when using Airsurpa.
- Patients at risk for decreased bone mineral density should be monitored during treatment with Airsurpa.
Side Effects
Headache, fungal infections of the mouth or throat, cough, and voice disorders are common side effects associated with Airsurpa; however, other side effects may also occur. Immediately inform your doctor of any side effects that bother you or won’t go away.
Searching for a competitive Airsurpa inhaler cost? You can buy an Airsurpa inhaler right here!
Reference
Airsupra. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2023.
IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.Product Code : 14640
-
Product Reviews
